ELV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ELV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-10), Elevance Health's share price is $538.94. Elevance Health's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $16.99. Hence, Elevance Health's Price to Tangible Book Ratio of today is 31.72.
The historical rank and industry rank for Elevance Health's Price-to-Tangible-Book or its related term are showing as below:
During the past 13 years, Elevance Health's highest Price to Tangible Book Ratio was 3208.40. The lowest was 20.48. And the median was 61.11.
A closely related ratio is called PB Ratio. As of today, Elevance Health's share price is $538.94. Elevance Health's Book Value per Sharefor the quarter that ended in Mar. 2024 was $174.62. Hence, Elevance Health's P/B Ratio of today is 3.09.
The historical data trend for Elevance Health's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Price-to-Tangible-Book | Get a 7-Day Free Trial | 29.91 | 37.47 | 92.08 | 79.00 | 29.58 |
Elevance Health Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Price-to-Tangible-Book | Get a 7-Day Free Trial | 93.34 | 47.03 | 38.73 | 29.58 | 30.52 |
For the Healthcare Plans subindustry, Elevance Health's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Elevance Health's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Elevance Health's Price-to-Tangible-Book falls into.
Elevance Health's price-to-tangible-book ratio for today is calculated as:
Price to Tangible Book | = | Share Price | / | Tangible Book per Share (Q: Mar. 2024 ) |
= | 538.94 | / | 16.99 | |
= | 31.72 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price to Tangible Book | = | Market Cap | / | Tangible Equity | ||||
= | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock | - | Intangible Assets) |
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Elevance Health's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Blair Williams Todt | officer: EVP and Chief Legal Officer | 8735 HENDERSON ROAD, TAMPA FL 33625 |
Ronald W Penczek | officer: SVP, Chief Accounting Officer | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Mark Kaye | officer: EVP & CFO Designate | 7 WORLD TRADE CENTER, 250 GREENWICH ST, NEW YORK NY 10007 |
Dixon Robert L Jr | director | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Gloria M Mccarthy | officer: EVP, Office of the CEO | WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Kendrick Charles Morgan Jr | officer: EVP & President, Commercial | 220 VIRGINIA AVE, INDIANAPOLIS IN 46204 |
Deanna D Strable-soethout | director | C/O PRINCIPAL FINANCIAL GROUP, 711 HIGH ST., DES MOINES IA 50392 |
Ramiro G Peru | director | WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46260 |
Peter D Haytaian | officer: EVP & Pres., Govt. Bus. Div. | 220 VIRGINIA AVE, INDIANAPOLIS IN 46204 |
Susan D. Devore | director | C/O PREMIER, INC., 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Ryan M. Schneider | director | 1680 CAPITAL ONE DRIVE, MCLEAN VA 22102 |
John E Gallina | officer: SVP & Chief Accounting Officer | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Julie A Hill | director | WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Thomas C Zielinski | officer: EVP & General Counsel | |
Jeffrey D. Alter | officer: EVP, IngenioRx & Anthem Health | 4330 LA JOLLA VILLAGE DRIVE, SUITE 200, SAN DIEGO CA 92122 |
From GuruFocus
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.